Treatment of keratoderma blennorrhagicum with tazarotene gel 0.1%.
We report near clearing of keratoderma blennorrhagicum following topical application of tazarotene gel 0.1%. This is the first report detailing the use of tazarotene gel for this purpose.
Lewis
A
A
Department of Dermatology, Baylor College of Medicine, Veteran's Affairs Medical Center, Houston, TX, USA.
Nigro
M
M
Rosen
T
T
D000287:Administration, Topical; D005533:Foot Dermatoses / Q000175:diagnosis / Q000188:drug therapy*; D005782:Gels; D006801:Humans; D007641:Keratolytic Agents / Q000008:administration & dosage* / Q000009:adverse effects; D007642:Keratosis / Q000175:diagnosis / Q000188:drug therapy*; D008297:Male; D008875:Middle Aged; D009539:Nicotinic Acids / Q000008:administration & dosage* / Q000009:adverse effects; D012176:Retinoids
D005782:Gels; D007641:Keratolytic Agents; D009539:Nicotinic Acids; C086827:tazarotene; D012176:Retinoids